Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Acadia Healthcare Company, Inc. (ACHC)

On September 1, 2024, The New York Times published a report on Acadia, one of the largest psychiatric hospital chains in the country. The article stated that a New York Times investigation found that “Acadia has lured patients into its facilities and held them against their will, even when detention was not medically necessary. In at least 12 of the 19 states where Acadia operates psychiatric hospitals, dozens of patients, staff and police officers have alerted authorities that the company was holding people in unlawful ways, according to records viewed by The Times. In some cases, judges have stepped in to force Acadia to release patients.”

Following this news, Acadia stock price fell $3.72 per share from $81.93 per share on September 1, 2024, to close at $78.21 on September 3, 2024.

If you purchased or otherwise acquired Acadia securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected] or by completing this CONTACT FORM to discuss your rights or interests with respect to these matters free of charge.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm focused on securities, antitrust, whistleblower and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in billions of dollars in awards.

This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and professional rules.

View original version on businesswire.com:

Acadia Healthcare stock at the time of publication of the news with a decline of -2.15 % up to 76.46USD on the Nasdaq stock exchange (September 6, 2024, 10:30 p.m.).